Anti-IgE therapy for management of recurrent ABPA exacerbations: successful outcome in 8 patients
M. Chopra (Kolkata, India), M. Chopra (KOLKATA, India), S. Babu Ps (KOLKATA, India)
Source: International Congress 2022 – Fungal infections and other relevant COVID-19 findings
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Chopra (Kolkata, India), M. Chopra (KOLKATA, India), S. Babu Ps (KOLKATA, India). Anti-IgE therapy for management of recurrent ABPA exacerbations: successful outcome in 8 patients. 1877
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|